Gene Mapping, Cloning and Sequencing
Genomic organization of the human NFAT5 gene: exon-intron structure of the 14-kb transcript and CpG-island analysis of the promoter regionDalski A. · Schwinger E. · Zühlke C.
Institut für Humangenetik, Universität Lübeck, Lübeck (Germany)
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
NFAT5, also known as tonicity enhancer binding protein (TonEBP) or NFATL1, is a new member of the immunologically important NFAT protein family. Despite its obvious relationship to this transcription factor family, NFAT5 shows distinct ways of regulation and function. The complete coding sequence and its alternative splice forms have been described previously. This sequence only refers to less than half of the total mRNA length. High conservation of this gene was shown among man, mouse, and pig. Here we report the cloning of the complete 14-kb cDNA sequence, its genomic organization, and a possible fourth isoform of the corresponding protein. Additionally, we describe the promoter region by CpG-island methylation analysis.
© 2001 S. Karger AG, Basel
- Dalski A, Wagner H-J, Schwinger E, Zühlke Ch: Quantitative PCR analysis of different splice forms of NFAT5 revealed specific gene expression in fetal and adult brain. Mol Brain Res 83:125–127 (2000).
- Frohman MA: Rapid amplification of complementary DNA ends for generation of full-length complementary DNAs: thermal RACE. Meth Enzym 218:340–356 (1993).
- Hebinck A, Dalski A, Engel H, Mattei MG, Hawken R, Schwinger E, Zühlke C: Assignment of transcription factor NFAT5 to human chromosome 16q22.1, murine chromosome 8D and porcine chromosome 6p1.4 and comparison of the polyglutamine domains. Cytogenet Cell Genet 90:68–70 (2000).
- López-Rodríguez C, Aramburu J, Rakeman AS, Copeland NG, Gilbert DJ, Thomas S, Disteche C, Jenkins NA, Rao A: NFAT5: The NF-AT family of transcription factors expands in a new direction. Cold Spring Harbor Symp 64:517–526 (1999).
- Miyakawa H, Woo SK, Dahl SC, Handler JS, Kwon HM: Tonicity-responsive enhancer binding protein, a Rel-like protein that stimulates transcription in response to hypertonicity. Proc natl Acad Sci, USA 96:2538–2542 (1999).
Serfling E, Berberich-Siebelt F, Chucpilo S, Jankevics E, Klein-Hessling S, Twardzik T, Avots A: The role of NF-AT transcription factors in T cell activation and differentiation. Biochem biophys Acta 1498:1–18 (2000).
Trama J, Lu Q, Hawley RG, Ho SN: The NFAT-related protein NFATL1 (TonEBP/NFAT5) is induced upon T cell activation in a calcineurin-dependent manner. J Immun 165:4884–4894 (2000).
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.